These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3715798)

  • 1. The effect of sodium warfarin on rabbit monocyte tissue factor expression.
    Edwards RL; Schreiber E; Brande W
    Thromb Res; 1986 Apr; 42(2):125-37. PubMed ID: 3715798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.
    Zivelin A; Rao LV; Rapaport SI
    J Clin Invest; 1993 Nov; 92(5):2131-40. PubMed ID: 8227329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation.
    Edwards RL; Rickles FR; Cronlund M
    J Lab Clin Med; 1981 Dec; 98(6):917-28. PubMed ID: 7310230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte tissue factor activity in anticoagulant-treated patients.
    Zacharski LR; Beck JR
    Thromb Res; 1983 Jan; 29(2):207-13. PubMed ID: 6845276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of Warfarin and factor VII on tissue procoagulant activity and pulmonary seeding.
    Francis JL; Carty N; Amirkhosravi M; Loizidou M; Cooper A; Taylor I
    Br J Cancer; 1992 Mar; 65(3):329-34. PubMed ID: 1558784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a warfarin-sensitive serum factor that participates in factor X activation by Lewis lung tumor cells.
    Fasco MJ; Wilson AC; Lincoln D; Gierthy J
    Int J Cancer; 1987 May; 39(5):631-7. PubMed ID: 3570555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of canine factor VII deficient substrate plasma.
    Gaston LW; Spivack AR
    J Lab Clin Med; 1968 Oct; 72(4):548-55. PubMed ID: 5677303
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoclonal anti-human factor VII antibodies. Detection in plasma of a second protein antigenically and genetically related to factor VII.
    Broze GJ; Hickman S; Miletich JP
    J Clin Invest; 1985 Sep; 76(3):937-46. PubMed ID: 2995451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of factor VII in the plasma of normal and warfarin-treated individuals by radioimmunoassay.
    Fair DS
    Blood; 1983 Oct; 62(4):784-91. PubMed ID: 6882924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma PIVKA proteins in rabbits given warfarin.
    Zivelin A; Rao LV; Rapaport SI
    Thromb Res; 1996 Jun; 82(5):429-38. PubMed ID: 8771703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological properties of the thromboplastins and plasmas included in the ICTH/ICSH collaborative study on prothrombin time standardization.
    Loeliger EA; van Halem-Visser LP
    Thromb Haemost; 1979 Dec; 42(4):1115-27. PubMed ID: 542924
    [No Abstract]   [Full Text] [Related]  

  • 12. Tissue factor-like activity of the human monocytic tumor cell line U937.
    Hudig D; Bajaj SP
    Thromb Res; 1982 Aug; 27(3):321-32. PubMed ID: 6753233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active and inactive factor VII in Dubin-Johnson syndrome with factor-VII deficiency, hereditary factor-VII deficiency and on coumadin administration.
    Levanon M; Rimon S; Shani M; Ramot B; Goldberg E
    Br J Haematol; 1972 Dec; 23(6):669-77. PubMed ID: 4675008
    [No Abstract]   [Full Text] [Related]  

  • 14. Warfarin-induced factor VII deficiency and the bleeding time.
    Green D; Ts'ao CH
    Thromb Res; 1983 Feb; 29(4):403-6. PubMed ID: 6857590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of inhibitors of arachidonic acid metabolism on thromboplastin activity in human monocytes.
    Crutchley DJ
    Biochem Biophys Res Commun; 1984 Feb; 119(1):179-84. PubMed ID: 6422935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of subacute oral warfarin administration on peripheral blood granulocytes in rats.
    Belij S; Miljković D; Popov A; Subota V; Timotijević G; Slavić M; Mirkov I; Kataranovski D; Kataranovski M
    Food Chem Toxicol; 2012 May; 50(5):1499-507. PubMed ID: 22342526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue factor pathway inhibitor activity in factor VII deficiency.
    Cella G; Vianello A; Boeri G; Toffoli S; Paolini R; Rampin E; Girolami A
    J Med; 1995; 26(3-4):189-91. PubMed ID: 8558100
    [No Abstract]   [Full Text] [Related]  

  • 18. Human monocytes have prothrombin cleaving activity.
    Hogg N
    Clin Exp Immunol; 1983 Sep; 53(3):725-30. PubMed ID: 6352100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage procoagulants.
    Edwards RL; Rickles FR
    Prog Hemost Thromb; 1984; 7():183-209. PubMed ID: 6397766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on immunological assay of vitamin K dependent factors. I. Measurement of factor VII antigen by radioimmunoassay.
    Mikami S; Tuddenham EG
    Br J Haematol; 1986 Jan; 62(1):171-81. PubMed ID: 3484635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.